Let's Build Better Cells Together

Navigate your way from concept to clinic by partnering with MaxCyte^®.

We've spent over 20 years perfecting the art of cell engineering and venturing beyond today's process to innovate tomorrow's solutions. Our ExPERT™ instruments feature best-in-class electroporation technology combining high efficiency and cell viability with seamless scalability, all backed by a global team of technical and regulatory experts providing ongoing support.

We provide the spark of collaboration empowering research into treatments and cures that will transform human health. Chart your best course with MaxCyte.

Electroporation Systems

Achieve efficient delivery that's consistent and scalable.

View all instruments

Technology

Find out how over 20 years of optimization delivers unparalleled performance.

Discover how our technology works

Support

Move confidently with experienced cell engineering specialists at your side.

Understand our technical & regulatory support

Research Applications

Cell Therapy

Discover scalable engineering to enable safe and potent cell therapies.

Cell Based Assays

Produce assay-ready cells faster with scalable electroporation.

Antibody & Protein Production

Accelerate biotherapeutic development with transient expression for gram-scale protein production.

Viral Vector Production

Transfect adherent or suspension cells to produce a variety of viral vectors.

Gene Editing

Navigate the complexities of genome engineering with highly efficient delivery.

Vaccine Development

Innovate vaccine research with our adaptable platform for production of recombinant proteins, virus-like particles and more.

Explore the research we've supported

See how MaxCyte technology is advancing our partners' biomedical innovations

Application Note

Triple-Engineered NYCE cells as T Cell Therapy for Refractory Cancers

Poster

Clinical Scale Delivery of nS/MARt Vectors for CAR T Cell Engineering

Application Note

Highly Efficient CAR T Cell Engineering, with CRISPR and Single-Stranded Cas9 Target Sequences.

We're here throughout your journey

Because bringing a new therapeutic to market is a long and complex endeavor, we offer our expertise to support your innovations and chart a more direct course to success.

The benefits of our collaborative approach can be seen in over 35 clinical trials. Our technology has enabled studies by leaders in pharmaceutical and biotechnology research developing treatments for a variety of indications including cancer, heart disease, central nervous system disorders and rare genetic diseases.

Learn More About Us